GFM2
Ribosome-releasing factor 2, mitochondrial
Also known as: EF-G2mt, EFG2, FLJ21661, RRF2M_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q969S9
- Gene
- GFM2
- Ensembl
- ENSG00000164347
- Chromosome
- 5
- Canonical length
- 779 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Midbody ring,Mitochondria
OverviewNCBI Gene
Eukaryotes contain two protein translational systems, one in the cytoplasm and one in the mitochondria. Mitochondrial translation is crucial for maintaining mitochondrial function and mutations in this system lead to a breakdown in the respiratory chain-oxidative phosphorylation system and to impaired maintenance of mitochondrial DNA. This gene encodes one of the mitochondrial translation elongation factors, which is a GTPase that plays a role at the termination of mitochondrial translation by mediating the disassembly of ribosomes from messenger RNA . Its role in the regulation of normal mitochondrial function and in disease states attributed to mitochondrial dysfunction is not known. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
779 residues, UniProt reviewed canonical sequence.
>Q969S9|GFM2
1 MLTNLRIFAM SHQTIPSVYI NNICCYKIRA SLKRLKPHVP LGRNCSSLPG LIGNDIKSLH
61 SIINPPIAKI RNIGIMAHID AGKTTTTERI LYYSGYTRSL GDVDDGDTVT DFMAQERERG
121 ITIQSAAVTF DWKGYRVNLI DTPGHVDFTL EVERCLRVLD GAVAVFDASA GVEAQTLTVW
181 RQADKHNIPR ICFLNKMDKT GASFKYAVES IREKLKAKPL LLQLPIGEAK TFKGVVDVVM
241 KEKLLWNCNS NDGKDFERKP LLEMNDPELL KETTEARNAL IEQVADLDDE FADLVLEEFS
301 ENFDLLPAEK LQTAIHRVTL AQTAVPVLCG SALKNKGIQP LLDAVTMYLP SPEERNYEFL
361 QWYKDDLCAL AFKVLHDKQR GPLVFMRIYS GTIKPQLAIH NINGNCTERI SRLLLPFADQ
421 HVEIPSLTAG NIALTVGLKH TATGDTIVSS KSSALAAARR AEREGEKKHR QNNEAERLLL
481 AGVEIPEPVF FCTIEPPSLS KQPDLEHALK CLQREDPSLK VRLDPDSGQT VLCGMGELHI
541 EIIHDRIKRE YGLETYLGPL QVAYRETILN SVRATDTLDR TLGDKRHLVT VEVEARPIET
601 SSVMPVIEFE YAESINEGLL KVSQEAIENG IHSACLQGPL LGSPIQDVAI TLHSLTIHPG
661 TSTTMISACV SRCVQKALKK ADKQVLEPLM NLEVTVARDY LSPVLADLAQ RRGNIQEIQT
721 RQDNKVVIGF VPLAEIMGYS TVLRTLTSGS ATFALELSTY QAMNPQDQNT LLNRRSGLTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GFM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 36 nTPM
Expression across tissuesHPA
Tissue
- tongue: 36 nTPM
- liver: 32 nTPM
- heart muscle: 31 nTPM
- skeletal muscle: 29 nTPM
- parathyroid gland: 29 nTPM
- fallopian tube: 22 nTPM
Single-cell type
- fallopian tube ciliated cells: 98 nCPM
- endometrial ciliated cells: 81 nCPM
- respiratory ciliated cells: 62 nCPM
- parietal cells: 57 nCPM
- sertoli cells: 54 nCPM
- foveolar cells: 54 nCPM
Immune cell
- basophil: 23 nTPM
- NK-cell: 16 nTPM
- non-classical monocyte: 12 nTPM
- eosinophil: 9.2 nTPM
- memory B-cell: 8.3 nTPM
- memory CD8 T-cell: 7.5 nTPM
Brain region
- choroid plexus: 37 nTPM
- cerebral cortex: 26 nTPM
- hypothalamus: 25 nTPM
- white matter: 24 nTPM
- basal ganglia: 24 nTPM
- pons: 24 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GFM2.
Disease | AllUniProt
Conditions GFM2 is implicated in, by any mechanism.
- Combined oxidative phosphorylation deficiency 39 (COXPD39) MIM:618397
Disease | GeneticClinVar
16 pathogenic / likely-pathogenic of 443 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Combined oxidative phosphorylation deficiency 39
- Mitochondrial disease
- See cases
- GFM2-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.04
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.8
- DepMap mean gene effect
- -0.25
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Elongation factor EFG, domain V-like
- Translational (tr)-type GTP-binding domain
- Small GTP-binding domain
- Translation elongation factor EFG/EF2, domain IV
- Translation protein, beta-barrel domain superfamily
- Elongation factor G, domain III
- Small ribosomal subunit protein uS5 domain 2-type fold, subgroup
- Ribosomal protein uS5 domain 2-type superfamily
- P-loop containing nucleoside triphosphate hydrolase
- Tr-type G domain, conserved site
- EF-G domain III/V-like
- EFG, domain V
- Elongation Factor G, domain II
- Elongation factor G-like, domain II
- Elongation factor Tu GTP binding domain
- Elongation factor G C-terminus
- Elongation factor G, domain IV
- Elongation Factor G, domain III
- Elongation factor G domain 2
- Ribosome-releasing factor 2, mitochondrial
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GFM2 as an antibody target. Whether an autoantibody or antibody against GFM2 could matter depends on whether native GFM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GFM2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GFM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...